TARGETED RELEASE RIFAXIMIN COMPOSITIONS

Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided. L'invention concerne des compositions...

Full description

Saved in:
Bibliographic Details
Main Authors ISRAEL, ROBERT J, LOWE, EZRA R, ROHRS, BRIAN R, COLE, JACOB, STEIN, DANIEL J
Format Patent
LanguageEnglish
French
Published 30.12.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are GI specific rifaximin release compositions which can be formulated for targeted delivery of rifaximin to one or more portions of the GI tract. Methods of treating diseases and disorders with the disclosed compositions are also provided. L'invention concerne des compositions de libération de rifaximine spécifiques au tractus gastro-intestinal qui peuvent être formulées pour une administration ciblée de rifaximine à une ou plusieurs parties du tractus gastro-intestinal. L'invention concerne également des procédés de traitement de maladies et de troubles avec les compositions décrites.
Bibliography:Application Number: CA20213184054